Datametrex AI (TSXV: DM) appears to be finally taking its name to heart and placing a focus on the development of its artificial intelligence tech. The firms Nexalogy subsidiary, which makes up the core of its AI tech, is reportedly working on developing something it refers to as AnalyticsGPT.
AnalyticsGPT, which is short for Analytics Generative Pre-Trained Transformer and is no doubt a reference to the popular ChatGPT Ai program, is said to be focused on both the general public and small medium enterprises, or SME’s. The tech driving the program is been in development behind the scenes for over a decade, and has exclusively been used by the government in different military-related activities.
AnalyticsGPT will be more accessible and geared towards small users as an offshoot of the firms NexaSMART and NexaIntelligence products. AnalyticsGPT intends to combine the data discovery, monitoring, and analysis functions of those programs with a user interface that is easy to use and intuitive for retail-level consumers. The basic version of the program is to run on what is referred to as a light engine, while AnalyticsGPT Plus will be geared towards professional researchers and analysts that require more intense computing power.
READ: Are Humans Doomed to Destroy ChatGPT?
“For years we have served government bodies and technology businesses with advanced AI solutions to improve their business needs. Generative Pre-Trained Transformer Technology is the future, and we are thrilled to combine our NexaSMART and NexaIntelligence software with generative technology to create a powerhouse solution that is not only available for businesses, but for the general public, too,” said CEO Marshall Gunter.
Datametrex currently owns two US patents on the tech behind the programs, and is in the process of obtaining a trademark for AnalyticsGPT.
Datametrex AI last traded at $0.155 on the TSX Venture.
Information for this briefing was found via Sedar and the companies mentioned. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
